Carmichael Hill & Associates, Inc. Invitae Corp Call Options Transaction History

Carmichael Hill & Associates, Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 Apr 05, 2023	BUY	$1.2 - $2.73 $960 - $2,184	800 Added 400.0%	1,000 $1,000
Q4 2022 Feb 13, 2023	SELL	$1.71 - $3.61 $2,052 - $4,332	-1,200 Reduced 85.71%	200 $0
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $4,396 - $10,913	700 Added 100.0%	1,400 $12,000
Q2 2021 Aug 03, 2021	BUY	$26.09 - $40.4 $5,218 - $8,080	200 Added 40.0%	700 $24,000
Q1 2020 May 05, 2020	BUY	$7.64 - $27.5 $3,820 - $13,750	500 New	500 $7,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.